FDA 483 - Merle Norman Cosmetics, Inc. - November 21, 2025

Merle Norman Cosmetics, Inc. in Los Angeles, CA, was cited for significant quality control deficiencies during an FDA inspection. The firm released out-of-specification batches, conducted inadequate investigations into discrepancies and customer complaints, and failed to provide sufficient employee training on revised procedures. Additional violations included unvalidated manufacturing processes, lack of cleaning validation for shared equipment, and insufficient raw material testing and supplier qualification.